These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2565965)

  • 1. The effect of some tricyclic antidepressants on the inhibition of mouse brain monoamine oxidase in-vivo by phenelzine.
    Green AL; O'Grady JE; Vass M
    J Pharm Pharmacol; 1989 Jan; 41(1):50-1. PubMed ID: 2565965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
    Marley E; Wozniak KM
    J Psychiatr Res; 1984; 18(2):173-89. PubMed ID: 6747915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of monoamine oxidase by tricyclic antidepressants: the influence of the nature of the substrate and the source of the enzyme.
    Green AL; McGachy HA
    J Pharm Pharmacol; 1987 May; 39(5):392-4. PubMed ID: 2886590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response.
    Heydendael W; Jacobson L
    Brain Res; 2008 Oct; 1238():93-107. PubMed ID: 18761333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress reduces in vivo inhibition of monoamine oxidase by phenelzine in rat brain.
    Clow A; Glover V; Oxenkrug GF; Sandler M
    Neurosci Lett; 1989 Dec; 107(1-3):331-4. PubMed ID: 2616044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the acute effects of a tricyclic and a MAOI antidepressant on septal driving of hippocampal rhythmical slow activity.
    Zhu XO; McNaughton N
    Psychopharmacology (Berl); 1994 Mar; 114(2):337-44. PubMed ID: 7838927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants.
    Lucki I; Frazer A
    Psychopharmacology (Berl); 1982; 77(3):205-11. PubMed ID: 6812141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining tricyclic and monoamine oxidase inhibitor antidepressants.
    Spiker DG; Pugh DD
    Arch Gen Psychiatry; 1976 Jul; 33(7):828-30. PubMed ID: 942286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase.
    Andree TH; Clarke DE
    Biochem Pharmacol; 1982 Mar; 31(5):825-30. PubMed ID: 7082351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of dosage in prescribing antidepressants.
    Quitkin FM
    Br J Psychiatry; 1985 Dec; 147():593-7. PubMed ID: 3913485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenoceptors and antidepressants: possible 2-phenylethylamine mediation of chronic phenelzine effects.
    McManus DJ; Mousseau DD; Paetsch PR; Wishart TB; Greenshaw AJ
    Biol Psychiatry; 1991 Dec; 30(11):1122-30. PubMed ID: 1663791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.
    Pohl R; Berchou R; Rainey JM
    J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
    Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K
    J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo.
    Green AL; El Hait MA
    J Pharm Pharmacol; 1980 Apr; 32(4):262-6. PubMed ID: 6103055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat.
    Coutts RT; Mozayani A; Danielson TJ; Baker GB
    J Pharm Sci; 1991 Aug; 80(8):765-7. PubMed ID: 1791538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants.
    Will CC; Aird F; Redei EE
    Mol Psychiatry; 2003 Nov; 8(11):925-32. PubMed ID: 14593430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrazide antidepressants possess novel antileishmanial activity in vitro and in vivo.
    Evans AT; Croft SL; Peters W; Neal RA
    Ann Trop Med Parasitol; 1989 Feb; 83(1):19-24. PubMed ID: 2596901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mouse brain monoamine oxidase by (+)-amphetamine in vivo.
    Green AL; el Hait MA
    J Pharm Pharmacol; 1978 Apr; 30(4):262-3. PubMed ID: 24723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.